Screening occupational contact allergy to bisphenol F epoxy resin

Abstract

Independent contact allergies to DGEBF-R were rare, and screening with it was not found to be useful.

Contact allergy to reactive diluents and related aliphatic epoxy resins

“…Contact allergy to epoxy compounds has been an area of special interest at the Finnish Institute of Occupational Health (FIOH) , and our patients exposed to epoxy products are tested with an epoxy patch test series comprising not only commercial test substances but also many in‐house test substances. We have recently published our results on epoxy hardeners and bisphenol F epoxy resin . The aim of the present study was to retrospectively describe FIOH patients with allergic reactions to reactive diluents and structurally related aliphatic [non‐DGEBA/diglycidyl ether of bisphenol F (DGEBF)] epoxy resins from the last two decades.…”

Independent contact allergy to bisphenol F epoxy resin: A case report

“…Because damaged skin facilitates the penetration of potential allergens, chronic allergic contact dermatitis with a "swimsuit distribution" in diapered infants can ensue. [1][2][3][4][5][6] In our case, the clinical history and the initial presentation of the lesions in the perineal area and inguinal folds were suggestive for an irritant diaper dermatitis that had probably facilitated penetration of allergens and led to a contact allergy from rubber chemicals. 4 Moreover, contact dermatitis from diapers due to rubber chemicals (mercaptobenzothiazole) or glues such as PTBFR has been reported.…”

“…[1][2][3] In this paper, we report a case of allergic diaper dermatitis in a 1-year-old boy, caused by benzothiazoles (mercapto compounds). [1][2][3] In this paper, we report a case of allergic diaper dermatitis in a 1-year-old boy, caused by benzothiazoles (mercapto compounds).…”

Recent Trends in Occupational Contact Dermatitis

“…The screening with DGEBF-R was not found to be useful. In some cases, the diagnosis of occupational allergic contact dermatitis requires testing with DGEBF-R or with the patients' own DGEBFbased products [42].…”